TETRACYCLIC CARBOLINE DERATIVES FOR INHIBITING ANGIOGENESIS
申请人:PTC Therapeutics, Inc.
公开号:EP1732543B1
公开(公告)日:2017-05-10
Tetra-Cyclic Carboline Derivatives Useful in the Inhibition of Angiogenesis
申请人:Moon Young-Choon
公开号:US20080182866A1
公开(公告)日:2008-07-31
In accordance with the present invention, tetracyclic caboline derivatives that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, these compounds useful in the inhibition of VEGF production, in the inhibition of angiogenesis, and/or in the treatment of cancer, diabetic retinopathy or exudative macular degeneration are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the inhibition of angiogenesis, and/or the treatment of cancer, diabetic retinopathy or exudative macular degeneration using the compounds of the invention.
US8940896B2
申请人:——
公开号:US8940896B2
公开(公告)日:2015-01-27
[EN] TETRA-CYCLIC CARBOLINE DERIVATIVES FOR INHIBITING ANGIOGENESIS<br/>[FR] DERIVES DE CARBOLINE TETRA-CYCLIQUE UTILES POUR INHIBER L'ANGIOGENESE